{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:36:28Z","timestamp":1784806588641,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20OC0065260"],"award-info":[{"award-number":["NNF20OC0065260"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF22OC0080141"],"award-info":[{"award-number":["NNF22OC0080141"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","award":["19175"],"award-info":[{"award-number":["19175"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","award":["53132"],"award-info":[{"award-number":["53132"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xphs.2026.104212","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:01:19Z","timestamp":1771488079000},"page":"104212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rule-based mitigation of charge asymmetry-triggered monoclonal antibody self-assembly"],"prefix":"10.1016","volume":"115","author":[{"given":"Inna","family":"Brakti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"\u0141ucja Tomczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Lyhne","family":"Godsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Lenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-0568","authenticated-orcid":false,"given":"Vito","family":"Foder\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9982-1980","authenticated-orcid":false,"given":"Minna","family":"Groenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2024.2443538","article-title":"Antibodies to watch in 2025","volume":"17","author":"Crescioli","year":"2025","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2023.2205540","article-title":"A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations","volume":"15","author":"Ghosh","year":"2023","journal-title":"MAbs"},{"issue":"32","key":"10.1016\/j.xphs.2026.104212_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abb0372","article-title":"A single molecular descriptor to predict solution behavior of therapeutic antibodies","volume":"6","author":"Kingsbury","year":"2020","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0004","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/acs.molpharmaceut.5b00937","article-title":"Pharmaceutical perspective on opalescence and liquid\u2013Liquid phase separation in protein solutions","volume":"13","author":"Raut","year":"2016","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0005","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0006","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/jps.23018","article-title":"Protein instability and immunogenicity: roadblocks to clinical application of injectable Protein delivery systems for sustained release","volume":"101","author":"Jiskoot","year":"2012","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0007","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-3549(15)00180-X","article-title":"Subvisible particle content, formulation, and dose of an erythropoietin peptide mimetic product are associated with severe adverse postmarketing events","volume":"105","author":"Kotarek","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104212_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2022.122490","article-title":"In vitro and in vivo immunogenicity assessment of protein aggregate characteristics","volume":"631","author":"Thorlaksen","year":"2023","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2026.104212_bib0009","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/acs.jpcb.4c07064","article-title":"Growth of clusters toward liquid\u2013Liquid phase separation of monoclonal antibodies as characterized by small-angle X-ray scattering and molecular dynamics simulation","volume":"29","author":"Kimball","year":"2025","journal-title":"J Phys Chem B"},{"issue":"9","key":"10.1016\/j.xphs.2026.104212_bib0010","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jps.20347","article-title":"Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution","volume":"94","author":"Liu","year":"2005","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0011","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/jps.21898","article-title":"Specific interactions in high concentration antibody solutions resulting in high viscosity","volume":"99","author":"Yadav","year":"2010","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104212_bib0012","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/jps.21322","article-title":"Reversible self-association of a concentrated monoclonal antibody solution mediated by fab\u2013Fab interaction that impacts solution viscosity","volume":"97","author":"Kanai","year":"2008","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104212_bib0013","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jbiosc.2011.06.017","article-title":"Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition","volume":"112","author":"Nishi","year":"2011","journal-title":"J Biosci Bioeng"},{"issue":"12","key":"10.1016\/j.xphs.2026.104212_bib0014","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1002\/jps.22190","article-title":"Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies","volume":"99","author":"Yadav","year":"2010","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4161\/19420862.2014.985504","article-title":"Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions","volume":"7","author":"Nichols","year":"2015","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0016","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/acs.molpharmaceut.0c01138","article-title":"Suppression of electrostatic mediated antibody liquid\u2013Liquid phase separation by charged and noncharged preferentially excluded excipients","volume":"18","author":"Banks","year":"2021","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0017","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/acs.molpharmaceut.5b00817","article-title":"Therapeutic antibody engineering to improve viscosity and phase separation guided by crystal structure","volume":"13","author":"Chow","year":"2016","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0018","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/19420862.2015.1016696","article-title":"Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics","volume":"7","author":"Datta-Mannan","year":"2015","journal-title":"MAbs"},{"issue":"15","key":"10.1016\/j.xphs.2026.104212_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2210332120","article-title":"Surface patches induce nonspecific binding and phase separation of antibodies","volume":"120","author":"Ausserw\u00f6ger","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0232713","article-title":"Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design","volume":"15","author":"Apgar","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2026.104212_bib0021","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.csbj.2024.05.041","article-title":"A framework for the biophysical screening of antibody mutations targeting solvent-accessible hydrophobic and electrostatic patches for enhanced viscosity profiles","volume":"23","author":"Armstrong","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"issue":"7","key":"10.1016\/j.xphs.2026.104212_bib0022","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1007\/s11095-011-0410-0","article-title":"Establishing a link between amino acid sequences and self-associating and viscoelastic behavior of two closely related monoclonal antibodies","volume":"28","author":"Yadav","year":"2011","journal-title":"Pharm Res"},{"issue":"52","key":"10.1016\/j.xphs.2026.104212_bib0023","doi-asserted-by":"crossref","first-page":"18601","DOI":"10.1073\/pnas.1421779112","article-title":"In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability","volume":"111","author":"Sharma","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0024","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acs.molpharmaceut.0c01073","article-title":"Machine learning applied to determine the molecular descriptors responsible for the viscosity behavior of concentrated therapeutic antibodies","volume":"18","author":"Lai","year":"2021","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11095-012-0965-4","article-title":"Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities","volume":"30","author":"Saito","year":"2013","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2026.104212_bib0026","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/mp200566k","article-title":"The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions","volume":"9","author":"Yadav","year":"2012","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104212_bib0027","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s11095-014-1352-0","article-title":"Dipole-Dipole interaction in antibody solutions: correlation with viscosity behavior at high concentration","volume":"31","author":"Singh","year":"2014","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2019.1692764","article-title":"Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies","volume":"12","author":"Tilegenova","year":"2020","journal-title":"Mabs"},{"issue":"10","key":"10.1016\/j.xphs.2026.104212_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0240673","article-title":"Mitigation of liquid\u2013liquid phase separation of a monoclonal antibody by mutations of negative charges on the Fab surface","volume":"15","author":"Matsuoka","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-biophys-121219-081629","article-title":"Physical principles underlying the complex biology of intracellular phase transitions","volume":"49","author":"Choi","year":"2020","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.xphs.2026.104212_bib0031","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.molliq.2017.11.106","article-title":"Controlling the viscosities of antibody solutions through control of their binding sites","volume":"270","author":"Kastelic","year":"2018","journal-title":"J Mol Liq"},{"issue":"6","key":"10.1016\/j.xphs.2026.104212_bib0032","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1021\/acs.molpharmaceut.9b00019","article-title":"A colloid approach to self-assembling antibodies","volume":"16","author":"Skar-Gislinge","year":"2019","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104212_bib0033","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1080\/19420862.2016.1222342","article-title":"Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity","volume":"8","author":"Arora","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.xphs.2026.104212_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.30294","article-title":"Intrinsically disordered linkers determine the interplay between phase separation and gelation in multivalent proteins","volume":"6","author":"Harmon","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.xphs.2026.104212_bib0035","series-title":"Computer-Aided Antibody Design","first-page":"219","article-title":"Structure-based optimization of antibody-based biotherapeutics for improved developability: a practical guide for molecular modelers","author":"Thorsteinson","year":"2023"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/19420862.2015.1099773","article-title":"Computational tool for the early screening of monoclonal antibodies for their viscosities","volume":"8","author":"Agrawal","year":"2016","journal-title":"MAbs"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0037","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acs.molpharmaceut.3c00191","article-title":"Using cluster theory to calculate the experimental structure factors of antibody solutions","volume":"20","author":"Skar-Gislinge","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104212_bib0038","unstructured":"Molecular Operating Environment (MOE), 2024.0601 Chemical Computing Group ULC, 910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7, 2025."},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0039","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/ci900508k","article-title":"LowModeMD\u2014Implicit low-mode velocity filtering applied to conformational search of macrocycles and protein loops","volume":"50","author":"Labute","year":"2010","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/prot.22234","article-title":"Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures","volume":"75","author":"Labute","year":"2009","journal-title":"Proteins:Struct, Funct, Bioinf"},{"key":"10.1016\/j.xphs.2026.104212_bib0041","series-title":"Protein Aggregation","first-page":"297","article-title":"Reproducible formation of insulin superstructures: amyloid-like fibrils, spherulites, and particulates","volume":"2023","author":"Thorlaksen","year":"2023"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0042","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1107\/S1600576720013412","article-title":"ATSAS 3.0 : expanded functionality and new tools for small-angle scattering data analysis","volume":"54","author":"Manalastas-Cantos","year":"2021","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2026.104212_bib0043","series-title":"Methods Mol. Biol","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-0716-1450-1_14","article-title":"Measuring self-association of antibody lead candidates with dynamic light scattering. Therapeutic antibodies","author":"Dingfelder","year":"2022"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0044","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jps.23786","article-title":"Unmasking translucent protein particles by improved micro-flow imaging\u2122 algorithms","volume":"103","author":"Pedersen","year":"2014","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0045","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.xphs.2021.02.002","article-title":"A multi-method approach to assess the self-interaction behavior of Infliximab","volume":"110","author":"Domnowski","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104212_bib0046","article-title":"Dissecting the molecular origins of opalescence and phase separation in mAb formulations and their relation to aggregation","author":"Brakti","year":"2025","journal-title":"bioRxiv Preprint"},{"issue":"2","key":"10.1016\/j.xphs.2026.104212_bib0047","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/jp512027j","article-title":"Charge-induced patchy attractions between proteins","volume":"119","author":"Li","year":"2015","journal-title":"J Phys Chem B"},{"issue":"6","key":"10.1016\/j.xphs.2026.104212_bib0048","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jps.23964","article-title":"Small-angle X-ray scattering screening complements conventional biophysical analysis: comparative structural and biophysical analysis of monoclonal antibodies IgG1, IgG2, and IgG4","volume":"103","author":"Tian","year":"2014","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104212_bib0049","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1021\/acs.molpharmaceut.3c00484","article-title":"Characterizing protein\u2013Protein interactions and viscosity of a monoclonal antibody from low to high concentration using small-angle X-ray scattering and molecular dynamics simulations","volume":"20","author":"Chowdhury","year":"2023","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2026.104212_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41570-022-00438-x","article-title":"Non-specificity as the sticky problem in therapeutic antibody development","volume":"6","author":"Ausserw\u00f6ger","year":"2022","journal-title":"Nat Rev Chem"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0051","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/acs.molpharmaceut.3c00090","article-title":"The relationship between protein\u2013Protein interactions and liquid\u2013Liquid phase separation for monoclonal antibodies","volume":"20","author":"Sibanda","year":"2023","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104212_bib0052","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nprot.2014.116","article-title":"Synchrotron-based small-angle X-ray scattering of proteins in solution","volume":"9","author":"Skou","year":"2014","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.xphs.2026.104212_bib0053","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acs.molpharmaceut.3c01023","article-title":"Combining scattering experiments and colloid theory to characterize charge effects in concentrated antibody solutions","volume":"21","author":"Gulotta","year":"2024","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104212_bib0054","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1023\/B:PHAM.0000032993.98705.73","article-title":"Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association","volume":"21","author":"Sukumar","year":"2004","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-010-9205-1","article-title":"Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations","volume":"12","author":"Sharma","year":"2010","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.xphs.2026.104212_bib0056","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1208\/s12248-013-9522-2","article-title":"Flow imaging microscopy for protein particle analysis-A comparative evaluation of four different analytical instruments","volume":"15","author":"Z\u00f6lls","year":"2013","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2026.104212_bib0057","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11095-011-0563-x","article-title":"Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations","volume":"29","author":"Saito","year":"2012","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2021.1981805","article-title":"Structure-based charge calculations for predicting isoelectric point, viscosity, clearance, and profiling antibody therapeutics","volume":"13","author":"Thorsteinson","year":"2021","journal-title":"MAbs"},{"issue":"9","key":"10.1016\/j.xphs.2026.104212_bib0059","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41557-023-01244-8","article-title":"Mass photometric detection and quantification of nanoscale \u03b1-synuclein phase separation","volume":"15","author":"Ray","year":"2023","journal-title":"Nat Chem"},{"key":"10.1016\/j.xphs.2026.104212_bib0060","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/s41557-023-01289-9","article-title":"The interface of condensates of the hnRNPA1 low-complexity domain promotes formation of amyloid fibrils","volume":"15","author":"Linsenmeier","year":"2023","journal-title":"Nat Chem"},{"issue":"9","key":"10.1016\/j.xphs.2026.104212_bib0061","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1110\/ps.072957907","article-title":"Patterns of protein\u2013protein interactions in salt solutions and implications for protein crystallization","volume":"16","author":"Dumetz","year":"2007","journal-title":"Protein Sci"},{"key":"10.1016\/j.xphs.2026.104212_bib0062","series-title":"Computational Pharmaceutics","article-title":"Molecular modeling for protein aggregation and formulation","author":"Roberts","year":"2015"},{"key":"10.1016\/j.xphs.2026.104212_bib0063","series-title":"Electrostatic Forces between Surfaces in Liquids. Intermolecular and Surface Forces","first-page":"291","author":"Israelachvili","year":"2011"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.20727","article-title":"Antibody structure, instability, and formulation","volume":"96","author":"Wang","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104212_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0066","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","article-title":"IgG4 breaking the rules","volume":"105","author":"Aalberse","year":"2002","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.xphs.2026.104212_bib0067","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.xphs.2022.11.010","article-title":"Effects of salts and surface charge on the biophysical stability of a low pI monoclonal antibody","volume":"112","author":"Rembert","year":"2023","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104212_bib0068","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1021\/acs.molpharmaceut.2c00453","article-title":"Understanding the stabilizing effect of histidine on mAb aggregation: a molecular dynamics study","volume":"19","author":"Saurabh","year":"2022","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104212_bib0069","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/acs.molpharmaceut.3c00963","article-title":"Unraveling the microscopic mechanism of molecular ion interaction with monoclonal antibodies: impact on protein aggregation","volume":"21","author":"Saurabh","year":"2024","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2026.104212_bib0070","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/bit.28239","article-title":"Machine learning approaches to root cause analysis, characterization, and monitoring of subvisible particles in monoclonal antibody formulations","volume":"119","author":"Greenblott","year":"2022","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.xphs.2026.104212_bib0071","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s11095-010-0125-7","article-title":"Phase separation of an IgG1 antibody solution under a low ionic strength condition","volume":"27","author":"Nishi","year":"2010","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104212_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2023.2285277","article-title":"Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume","volume":"15","author":"Desai","year":"2023","journal-title":"MAbs"},{"issue":"7","key":"10.1016\/j.xphs.2026.104212_bib0073","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s11095-024-03726-x","article-title":"Stability of protein pharmaceuticals: recent advances","volume":"41","author":"Manning","year":"2024","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104212_bib0074","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.xphs.2022.11.020","article-title":"An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations","volume":"112","author":"Desai","year":"2023","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:22:41Z","timestamp":1776446561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022354926000614"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104212","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rule-based mitigation of charge asymmetry-triggered monoclonal antibody self-assembly","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104212"}}